
Sign up to save your podcasts
Or


STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.
By STAT4.5
309309 ratings
STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.

30,727 Listeners

1,943 Listeners

493 Listeners

9,535 Listeners

6,071 Listeners

390 Listeners

62 Listeners

86 Listeners

33 Listeners

519 Listeners

5,522 Listeners

20 Listeners

51 Listeners

391 Listeners

12 Listeners